Form 4: Indivior CSO Executes Planned Stock Sale

Chief Scientific Officer Christian Heidbreder sold 18,586 shares of Indivior common stock via a Rule 10b5-1 trading plan.

Summary

• Christian Heidbreder, Chief Scientific Officer of Indivior, sold 18,586 shares of common stock.
• The transaction occurred on June 11, 2026, at a price of $38.06 per share.
• Following the sale, the reporting person retains beneficial ownership of 227,923 shares.
• The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on March 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned 10b5-1 arrangement, which is a standard practice for executive financial planning.

Positives

• The transaction was conducted under a pre-arranged Rule 10b5-1 plan, indicating the sale was not based on non-public information.

Negatives

• The sale represents a reduction in the insider's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on future stock performance.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard corporate governance practice for executives to manage personal liquidity and is generally viewed as neutral by institutional investors.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to avoid potential conflicts of interest regarding insider trading regulations.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and represents a small portion of the executive's total holdings.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Indivior, INDV, Insider Trading, Form 4, Christian Heidbreder, Chief Scientific Officer